Tranexamic Acid Tablet
Product Images NDC 71335-1981

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid (NDC 71335-1981). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

Chemical structure diagram of Tranexamic Acid showing its molecular configuration with labeled functional groups including an amino group (H2N) and a carboxylic acid group (CO2H).*

FDA Label Image

Figure 1 (Image 02)

A line graph showing mean menstrual blood loss (mL) over a treatment period across multiple cycles. The graph compares Tranexamic Acid Tablets 3900 mg in 3-cycle and 6-cycle studies to placebo groups for the same durations, with data points at baseline and through sixth treatment cycle.*

FDA Label Image

Label (Lbl713351981)

Tranexamic Acid 650 mg tablet packaging label from Bryant Ranch Prepack. The label states it is a white oval tablet and compares to Lysteda 650 mg tablet by Suzhou Amerigen Pharma Co. Ltd. It includes storage instructions for room temperature (20°-25°C) and a warning to keep out of reach of children. The label also shows NDC 71335-1981.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.